Healthy Clinical Trial - A Study to Examine the Effect of Daridorexant on

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04632485` - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Terminated	`NCT04556032` - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women	N/A
Completed	`NCT04998695` - Health Effects of Consuming Olive Pomace Oil	N/A
Completed	`NCT04107441` - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects	Phase 1
Completed	`NCT04065295` - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225	Phase 1
Completed	`NCT01442831` - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects	Phase 1
Recruiting	`NCT04967157` - Cognitive Effects of Citicoline on Attention in Healthy Men and Women	N/A
Completed	`NCT05030857` - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects	Phase 1
Recruiting	`NCT04494269` - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls	Phase 1
Recruiting	`NCT04714294` - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers	Phase 1
Completed	`NCT04539756` - Writing Activities and Emotions	N/A
Recruiting	`NCT04098510` - Concentration of MitoQ in Human Skeletal Muscle	N/A
Completed	`NCT03308110` - Bioavailability and Food Effect Study of Two Formulations of PF-06650833	Phase 1
Completed	`NCT04052711` - A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design	Phase 1
Terminated	`NCT00001844` - Study of New Magnetic Resonance Methods
Completed	`NCT04451811` - A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers	Phase 1
Completed	`NCT04319926` - Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects	Phase 1
Completed	`NCT03160261` - Effect of Exenatide on Cortisol Secretion	Phase 4
Completed	`NCT05392816` - Non-heme Iron Absorption From Single Meals of Fava Bean Protein, Beef Protein and Cod Protein	N/A
Completed	`NCT05005065` - Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians	Phase 1

NCT number	NCT05480475
Study type	Interventional
Source	Idorsia Pharmaceuticals Ltd.
Contact	Clinical Trial Disclosure Desk
Phone	+41 58 844 19 77
Email	[email protected]
Status	Not yet recruiting
Phase	Phase 1
Start date	September 2, 2022
Completion date	September 30, 2022

A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms